Diagnostic and surveillance testing capability for mpox in the EU/EEA, September 2024

Euro Surveill. 2024 Oct;29(42):2400632. doi: 10.2807/1560-7917.ES.2024.29.42.2400632.

Abstract

In response to the increasing number of mpox cases caused by monkeypox virus (MPXV) clade I in the African continent and the first reported travel-related clade Ib case of mpox in EU/EEA, the European Centre for Disease Prevention and Control surveyed national capability for detection and characterisation of MPXV in the EU/EEA. The results showed high level of capability for case confirmation by PCR, alongside molecular typing methods for identification of MPXV clades and/or clade I subclades within the EU/EEA.

Keywords: EU/EEA; MPXV; PCR; clade differentiation; diagnostic testing; laboratory capability; mpox; whole genome sequencing.

MeSH terms

  • Europe
  • European Union
  • Humans
  • Monkeypox virus* / genetics
  • Monkeypox virus* / isolation & purification
  • Mpox, Monkeypox* / diagnosis
  • Mpox, Monkeypox* / epidemiology
  • Mpox, Monkeypox* / virology
  • Phylogeny
  • Polymerase Chain Reaction
  • Population Surveillance
  • Travel